These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31606540)

  • 1. Inhomogeneous Distribution of Components in Solid Protein Pharmaceuticals: Origins, Consequences, Analysis, and Resolutions.
    Nguyen KTT; Frijlink HW; Hinrichs WLJ
    J Pharm Sci; 2020 Jan; 109(1):134-153. PubMed ID: 31606540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of novel excipients for freeze-dried protein formulations.
    Holm TP; Meng-Lund H; Rantanen J; Jorgensen L; Grohganz H
    Eur J Pharm Biopharm; 2021 Mar; 160():55-64. PubMed ID: 33508435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.
    Feng J; Markwalter CE; Tian C; Armstrong M; Prud'homme RK
    J Transl Med; 2019 Jun; 17(1):200. PubMed ID: 31200738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Lab Formulation Development to CTM Manufacturing of KO-947 Injectable Drug Products: a Case Study and Lessons Learned.
    Deng X; Ren P; Mai W; Wang Y; Zhang Y; Wu H; Xie Y; Chen H
    AAPS PharmSciTech; 2021 Jun; 22(5):168. PubMed ID: 34080070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Conference on the Freeze-Drying of Pharmaceuticals and Biologicals.
    Anchordoqu TJ
    Ther Deliv; 2011 Jan; 2(1):15-7. PubMed ID: 22833921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state.
    Abdul-Fattah AM; Lechuga-Ballesteros D; Kalonia DS; Pikal MJ
    J Pharm Sci; 2008 Jan; 97(1):163-84. PubMed ID: 17722086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches.
    Ziaee A; Albadarin AB; Padrela L; Femmer T; O'Reilly E; Walker G
    Eur J Pharm Sci; 2019 Jan; 127():300-318. PubMed ID: 30428336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.
    Chen Y; Mutukuri TT; Wilson NE; Zhou QT
    Adv Drug Deliv Rev; 2021 May; 172():211-233. PubMed ID: 33705880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze drying formulation using microscale and design of experiment approaches: a case study using granulocyte colony-stimulating factor.
    Grant Y; Matejtschuk P; Bird C; Wadhwa M; Dalby PA
    Biotechnol Lett; 2012 Apr; 34(4):641-8. PubMed ID: 22187075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters.
    Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G
    Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidate.
    Clénet D; Hourquet V; Woinet B; Ponceblanc H; Vangelisti M
    Eur J Pharm Biopharm; 2019 Sep; 142():334-343. PubMed ID: 31306751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
    Cleland JL; Jones AJ
    Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.